Additional file 9 of Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach

Additional file 9: Table S6. Summary for the DEG and DEP from RTT-MECP2 vs MDS and RTT-MECP2 versus RTT-like

Additional file 4 of Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach

Additional file 4: Table S1. Detailed description of the study cohort

Additional file 3 of Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach

Additional file 3: Fig. S3. Comparison of genes from Genotype-Tissue Expression (GTEx) project and mean TPM (Transcripts per Kilobase Million) in fibroblast cultured cells in RNAseq and RT-qPCR

Additional file 2 of Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach

Additional file 2: Fig. S2. Comparison of the gene expression results between RNAseq and RT-qPCR

Additional file 7 of Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach

Additional file 7: Table S4. Enrichment analysis results for the RTT-MECP2 versus healthy controls, RTT versus MDS, RTT versus RTT-like, transcriptomic and proteomic data

Additional file 6 of Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach

Additional file 6: Table S3. RNAseq and proteomics differential expression results for RTT - MECP2 versus healthy controls